Paul LePage: LIVING DONORS
In 2017, Bipartisan Majorities in the House and Senate Overrode LePage’s Veto of a Bill Prohibiting Insurers From Limiting or Refusing to Issue New Coverage to Living Organ Donors, Precluding Individuals from Donating an Organ, or Considering an Individual’s Status as a Donor in Determining the Rate for Coverage, or Otherwise Discriminating Against Such Individuals. In April 2017, the House overrode LePage’s veto of LD12 by a 146-0 vote and the Senate by a 32-2 vote. LD12 “prohibits an insurer authorized to do business in this State from: 1. Limiting coverage or refusing to issue or renew coverage of an individual under any life insurance, disability insurance or long-term care insurance policy due to the status of an individual as a living donor; 2. Precluding an individual from donating all or part of an organ as a condition of receiving coverage under a life insurance, disability insurance or long-term care insurance policy; 3. Considering the status of an individual as a living organ donor in determining the premium rate for coverage of that individual under a life insurance, disability insurance or long-term care insurance policy; or 4. Otherwise discriminating in the offering, issuance, cancellation, amount of coverage, price or other condition of a life insurance, disability insurance or long-term care insurance policy based solely and without any additional actuarial justification upon the status of an individual as a living organ donor.” [Summaries of Bills, LD12, 2017; Maine State Legislature, LD12, 2017]